Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
agilon health, inc. provides a healthcare services platform that partners with primary care physician groups and health systems to transition senior patient care to a value-based Total Care Model. Company updates commonly cover Medicare Advantage members and ACO model beneficiaries on the agilon platform, payor contract economics, market exits, clinical programs, data and technology investments, and operating discipline within a Medicare-centric capitated care model.
News also includes quarterly and annual financial results, revenue, medical margin and Adjusted EBITDA guidance, conference participation, and governance changes such as CEO appointments and board membership. Recurring disclosures tie membership trends, payor alignment and clinical execution to the economics of agilon’s physician partnerships.
Agilon Health, Inc. (NYSE: AGL) will release its financial results for Q4 and full year 2022 after market close on March 1, 2023. A conference call to discuss the results will be held at 4:30 PM ET. U.S. participants can join by calling (844) 200-6205, while international participants can dial +1 (929) 526-1599. The call can also be accessed via a webcast. Additionally, Agilon will participate in Cowen and Company’s 43rd Annual Health Care Conference on March 8, 2023.
Summary not available.
agilon health, inc. (NYSE: AGL) will participate in the 41st Annual J.P. Morgan Healthcare Conference with a fireside chat on January 9 at 12:45 PM Eastern Time. Investors can access a live webcast of the presentation on agilon's investor relations website. A replay will be available shortly after the event. agilon health partners with physician groups to transition to a value-based Total Care Model, aiming to enhance healthcare for senior patients. Currently, agilon operates in 17 diverse communities.
agilon health, inc. (NYSE: AGL) will participate in the 4th Annual Wolfe Research Healthcare Conference, featuring a fireside chat presentation on November 17 at 1:20 PM ET. Investors can access the live webcast through the 'Events & Presentations' section on agilon health's investor relations website. A replay will be available post-event. Agilon health partners with physician groups to enhance healthcare delivery through value-based models, supporting senior patients in 17 communities. For more information, visit www.agilonhealth.com.
Agilon Health, Inc. (NYSE: AGL) reported a 52% revenue increase to $695 million for Q3 2022, compared to $459 million in Q3 2021. Total membership grew 45% to 266,600 Medicare Advantage members, with total members on the platform reaching 356,000. The medical margin surged 74% to $76 million, representing 10.9% of revenue. Adjusted EBITDA improved to $15 million for the first nine months. Despite a net loss of $31 million for Q3, the outlook for FY 2022 reflects continued membership and revenue growth.
agilon health, inc. (NYSE: AGL) will release its Q3 2022 financial results on November 3, 2022, after the market closes. A conference call is scheduled for 5:00 PM ET on the same day, accessible by phone or through a webcast on the company’s Investor Relations site. The event aims to discuss the financial results and provide insights to investors. agilon health focuses on empowering physicians and transitioning to a value-based Total Care Model for senior patients, serving 17 communities.
agilon health, inc. (NYSE: AGL) announced its participation in two key investor conferences. The first is the Wells Fargo Healthcare Conference on September 8 at 10:25 AM ET, followed by the Morgan Stanley 20th Annual Global Healthcare Conference on September 14 at 3:30 PM ET. Investors can access live webcasts of these events through the agilon health investor relations website. The company focuses on empowering physicians to enhance healthcare services in communities, transitioning to a value-based Total Care Model for senior patients.
agilon health announces the retirement of Michael Smith from its board of directors after over five years. Jeff Schwaneke, previously Executive VP at Centene Corporation, will join as an independent board member. Schwaneke brings extensive experience including overseeing a $35 billion pharmacy business and a significant growth in revenues at Centene, from $20 billion to $125 billion. The company views this transition as crucial for its growth during an evolving healthcare landscape.
Summary not available.
Agilon Health (NYSE: AGL) reported significant financial growth for Q2 2022, with total revenue reaching $670 million, a 34% increase from Q2 2021. Year-to-date, revenue surged 45% to $1.32 billion. Medicare Advantage membership increased by 44%, totaling 261,200 members. The company's medical margin rose 49% to $82 million, reflecting a margin of 12.2% of revenue. Despite a net loss of $21 million, a notable improvement from a $299 million loss last year, Agilon reported an adjusted EBITDA of $7 million, up from negative $2 million.